Aptevo

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Aptevo and other ETFs, options, and stocks.

About APVO

Aptevo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages on developing novel immunotherapies for the treatment of cancer. Its pipeline APVO436, ALG.APV-527, and APVO603 were developed based on the ADAPTIR modular protein platform technology and APVO442 was developed based on the new ADAPTIR-FLE platform technology.

CEO

Marvin L. White

CEOMarvin L. White

Employees

Employees42

Headquarters

Seattle, Washington

HeadquartersSeattle, Washington

Founded

2016

Founded2016

Employees

Employees42

APVO Key Statistics

Market cap

3.20M

Market cap3.20M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

12.60M

Average volume12.60M

High today

$0.7167

High today$0.7167

Low today

$0.3099

Low today$0.3099

Open price

$0.3099

Open price$0.3099

Volume

119.44M

Volume119.44M

52 Week high

$32.93

52 Week high$32.93

52 Week low

$0.2425

52 Week low$0.2425

People also own

Based on the portfolios of people who own APVO. This list is generated using Robinhood data, and it’s not a recommendation.

Mullen Automotive

Tonix Pharmaceuticals